Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Researchers examine impact of diet for preventing Alzheimer's dementia

A cocktail of ingredients containing omega-3 fatty acid found in fish oil is being tested in patients with mild cognitive impairment as a means to slow the progression of Alzheimer's dementia down

19 Feb 2014

Neuropsychological assessment efficiently tracks disease progression in memory clinic patients

Investigators at the University of Amsterdam, The Netherlands, have shown that progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing. MRI measures of brain atrophy were shown to be less reliable to pick up changes in the same patients.

19 Feb 2014

Watching video of simple tasks may boost brain's structure, shows study

Watching video of simple tasks before carrying them out may boost the brain's structure, or plasticity, and increase motor skills, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. Brain plasticity is the brain's ability to flex and adapt, allowing for better learning.

19 Feb 2014

Researchers find new ways to elucidate creation of toxic oligomers associated with Alzheimer's disease

Researchers studying peptides using the Gordon supercomputer at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego (UCSD) have found new ways to elucidate the creation of the toxic oligomers associated with Alzheimer's disease.

19 Feb 2014

Researchers are unraveling the mysteries of amyloid beta peptides in Alzheimer's disease

Alzheimer's disease has long been marked by progress -- but not the kind of progress the medical community seeks. It is the most common form of dementia among older Americans, and its risk increases with increasing age; for those living with the disease, its ravages get worse over time; and as we move into the 21st century, it will place a greater and greater burden on society.

18 Feb 2014

Scientists discover link between ageing process and hormone released from muscle after exercise

Scientists from Aston University (UK) have discovered a potential molecular link between Irisin, a recently identified hormone released from muscle after bouts of exercise, and the ageing process.

18 Feb 2014

Scientists measure how well football helmet designs protected against traumatic brain injury

A new study finds that football helmets currently used on the field may do little to protect against hits to the side of the head, or rotational force, an often dangerous source of brain injury and encephalopathy.

18 Feb 2014

Vitamin C may reduce risk of most common type of hemorrhagic stroke, says study

Eating foods that contain vitamin C may reduce your risk of the most common type of hemorrhagic stroke, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

17 Feb 2014

Resolution of inflammation is altered in Alzheimer's disease

New research from Karolinska Institutet in Sweden shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease.

17 Feb 2014

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that it plans to discontinue the sale of NAMENDA (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.

16 Feb 2014

Research provides new insight into the effect of misfolded proteins in neurodegenerative disorders

Research by the University of Southampton has provided new insight into the consequence of accumulated 'misfolded proteins' in neurodegenerative disorders, such as Prion and Alzheimer's disease.

16 Feb 2014

Final stage of normal inflammatory process may be disrupted in patients with Alzheimer's disease

New research from Karolinska Institutet in Sweden shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease. A study published in the journal Alzheimer's & Dementia shows that levels in the brain and cerebrospinal fluid of the molecules necessary for tissue recovery through the clearance of harmful inflammatory substances are lower than normal in patients with Alzheimer's disease. The study also showed association between the lower levels of these molecules with impaired memory function.

14 Feb 2014

First record of direct link between Alzheimer's disease and elevated brain aluminium

Research at Keele University in Staffordshire, UK, has shown for the first time that an individual who was exposed to aluminium at work and died of Alzheimer's disease had high levels of aluminium in the brain.

14 Feb 2014

FAST-MAG clinical trial finds that magnesium does not improve stroke-related disability

In the first study of its kind, a consortium led by UCLA physicians found that giving stroke patients intravenous magnesium within an hour of symptom onset does not improve stroke outcomes, according to research presented today at the American Stroke Association's International Stroke Conference.

14 Feb 2014

Exposure to common infections linked to memory and brain function

Exposure to common infections is linked to memory and brain function - even if the infections never made you ill, according to research presented at the American Stroke Association's International Stroke Conference 2014.

13 Feb 2014

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

Prestige Care, Inc., and Prestige Senior Living L.L.C., leaders in exceptional senior living and skilled nursing and rehabilitation care, today announced that they are making plans to join with Carson Tahoe Health to expand quality senior care services and offer comprehensive memory care to Carson City residents and their families. As a first step in the relationship, the organizations will develop a community with 40 units for memory care services on the Carson Tahoe Specialty Medical Center campus. Construction will begin in 2014.

13 Feb 2014

Study to examine effectiveness of using video calls to deliver care for people with Parkinson's disease

People living with Parkinson's disease today often face challenges when seeking care, including disability, distance from medical centers, and distribution of doctors. In fact, 42 percent of those diagnosed with Parkinson's disease, and more living with the condition, do not see a neurologist for their care. Now, a national study will attempt to disrupt the status quo and bring expert Parkinson's care directly into patients' homes using video visit technology.

12 Feb 2014

Neuroscientists identify white matter "scaffold" of human brain

For the first time, neuroscientists have systematically identified the white matter "scaffold" of the human brain, the critical communications network that supports brain function.

12 Feb 2014

Red wine and dark chocolate taste great and have heart-healthy components

Forget the oysters and the champagne this Valentine's Day. If you want to keep your true love's heart beating strong, the real foods of love are dark chocolate and red wine, said Loyola University Health System preventive heart specialist Sara Sirna, MD.

12 Feb 2014

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2013, and provided an operating forecast and program updates.

11 Feb 2014

Alzheimer's Disease News and Research

Further Reading

Researchers examine impact of diet for preventing Alzheimer's dementia

Neuropsychological assessment efficiently tracks disease progression in memory clinic patients

Watching video of simple tasks may boost brain's structure, shows study

Researchers find new ways to elucidate creation of toxic oligomers associated with Alzheimer's disease

Researchers are unraveling the mysteries of amyloid beta peptides in Alzheimer's disease

Scientists discover link between ageing process and hormone released from muscle after exercise

Scientists measure how well football helmet designs protected against traumatic brain injury

Vitamin C may reduce risk of most common type of hemorrhagic stroke, says study

Resolution of inflammation is altered in Alzheimer's disease

Forest Laboratories plans to discontinue sale of NAMENDA 5 mg and 10 mg tablets

Research provides new insight into the effect of misfolded proteins in neurodegenerative disorders

Final stage of normal inflammatory process may be disrupted in patients with Alzheimer's disease

First record of direct link between Alzheimer's disease and elevated brain aluminium

FAST-MAG clinical trial finds that magnesium does not improve stroke-related disability

Exposure to common infections linked to memory and brain function

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

Study to examine effectiveness of using video calls to deliver care for people with Parkinson's disease

Neuroscientists identify white matter "scaffold" of human brain

Red wine and dark chocolate taste great and have heart-healthy components

Ligand Pharmaceuticals' total revenues for Q4 2013 increase 8% to $14.7 million

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News